Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial
Eye (Lond)
.
2024 Nov;38(16):3037-3038.
doi: 10.1038/s41433-024-03232-9.
Epub 2024 Jul 16.
Authors
Enrico Borrelli
1
2
,
Michele Reibaldi
3
4
,
Francesco Bandello
5
6
,
Paolo Lanzetta
7
8
,
Francesco Boscia
9
Affiliations
1
Department of Surgical Sciences, University of Turin, Turin, Italy. borrelli.enrico@yahoo.com.
2
Department of Ophthalmology, "City of Health and Science" Hospital, Turin, Italy. borrelli.enrico@yahoo.com.
3
Department of Surgical Sciences, University of Turin, Turin, Italy.
4
Department of Ophthalmology, "City of Health and Science" Hospital, Turin, Italy.
5
IRCCS San Raffaele Scientific Institute, Milan, Italy.
6
Vita-Salute San Raffaele University Milan, Milan, Italy.
7
Department of Medicine-Ophthalmology, University of Udine, Udine, Italy.
8
Istituto Europeo di Microchirurgia Oculare-IEMO, Udine, Milan, Italy.
9
Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro", Bari, Italy.
PMID:
39014207
PMCID:
PMC11544297
DOI:
10.1038/s41433-024-03232-9
No abstract available